Hepatitis C Testing Forecast Report 2025 – Designed for Product & Growth Teams

 Unlock 30% off global market reports with code ONLINE30 — get insights on tariff changes, macro trends, and global economic shifts.

 

 What is the current market size of the hepatitis c testing industry, and what growth rate is it expected to achieve?
 The hepatitis c testing market size has grown strongly in recent years. It will grow from $1.24 billion in 2024 to $1.32 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to the rise in hepatitis C prevalence, expansion of public health programs, rise in intravenous drug use, growing awareness of hepatitis C risks, and government funding for infectious disease control.
 
 The hepatitis c testing market size is expected to see strong growth in the next few years. It will grow to $1.68 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to rising demand for early disease detection, increasing healthcare access, growing emphasis on preventive healthcare, support from global health organizations, and government initiatives for hepatitis C elimination. Major trends in the forecast period include the adoption of multiplex diagnostic platforms, the integration of artificial intelligence (AI) in diagnostic tools, a shift toward home-based testing kits, increased collaboration for test development, and the development of low-cost testing solutions.
 
 Download Your Free Sample PDF:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp
 
 What are the major drivers contributing to the growth of the hepatitis c testing market?
 The rise in the prevalence of hepatitis cases is expected to propel the growth of the hepatitis C testing market going forward. Hepatitis C is a viral infection that causes liver inflammation and can lead to serious liver damage if left untreated. Hepatitis cases are increasing mainly because low vaccination rates leave many individuals unprotected, facilitating the virus’s spread. Hepatitis C testing allows for early virus detection, facilitating prompt treatment to avoid liver damage and serious complications. It also identifies infected individuals to help prevent the spread and enhance disease control. For instance, in April 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization responsible for global public health, over 50 million people are living with chronic hepatitis C virus infection globally, with approximately 1.0 million new infections occurring each year. Therefore, the rising prevalence of hepatitis cases is driving the growth of the hepatitis C testing market.
 
 What are the major market segments driving the growth of the hepatitis c testing industry?
 The hepatitis c testing market covered in this report is segmented –
 
 1) By Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests
 2) By Product: Test Kits, Instruments, Reagents, Consumables
 3) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing
 4) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis
 5) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users
 
 Subsegments:
 1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)
 2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)
 3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping
 
 View The Full Market Report:
 https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report
 
 What technological trends are expected to redefine the hepatitis c testing market?
 Major companies operating in the hepatitis C testing market are focused on developing advanced solutions such as dual antigen-antibody diagnostic tests to enable more effective screening and monitoring of the infection. An antigen-antibody diagnostic test detects viral proteins (antigens) and immune response proteins (antibodies) to identify both active and past infections. This dual approach offers a thorough evaluation of the infection status. For instance, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based provider of diagnostic tests and systems, launched Elecsys HCV Duo, a fully automated immunoassay capable of simultaneously and independently detecting both HCV antigens and antibodies from one plasma or serum sample. This innovation enables early diagnosis, supports patient management, and aligns with India’s national strategy to eliminate hepatitis C through timely and comprehensive screening.
 
 Who are the key market players contributing to the growth of the hepatitis c testing industry?
 Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, Abcam Plc, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited, BIOGENIX INC. PVT. LTD.
 
 Which regions are leading the growth of the hepatitis c testing market globally?
 North America was the largest region in the hepatitis C testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 How Can Companies Use The Hepatitis C Testing Market Report to Drive Business Results?
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 Purchase The Report And Get A Swift Delivery:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24559
 
 Need Customized Data On Hepatitis C Testing Market?
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 Request Customized Data:
 https://www.thebusinessresearchcompany.com/customise?id=24559&type=smp
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Americas +1 310–496-7795
 Asia +44 2071930708
 Europe +44 7882 955267
 Email us at info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company